Mergers & Acquisitions

Mercalis Merges With PharmaCord

6381 Mercalis NT

M&A Engagement Overview

Industry Group: Healthcare & Life Sciences
Areas of Focus: Outsourced Pharma Services, Commercialization Services

Harris Williams advised Mercalis, a portfolio company of Odyssey Investment Partners, on their merger with PharmaCord LLC, a portfolio company of Permira. Mercalis is an integrated life sciences commercialization partner that provides comprehensive solutions spanning the entire healthcare value chain.

The pharma services ecosystem is a massive market with strong secular tailwinds, including a shift towards specialty pharmaceuticals and increasing complexity in coverage and reimbursement. Additionally, there is a demand for data and consulting expertise and a continued trend toward outsourcing, driven by increasing competition between large pharmaceutical companies bringing new drugs to market.

By combining PharmaCord’s expertise in patient services with Mercalis’ advanced technology infrastructure, experienced commercial team, and fully integrated market access offerings, the new entity is poised to be a leading provider of patient access solutions to the biopharmaceutical industry. The merger will enhance the patient experience by improving access and affordability while addressing the complex challenges of adherence and retention, particularly for specialty medications.

The union of PharmaCord and Mercalis forms one of the largest independent patient access companies in the market, delivering the full breadth of solutions with greater reach and efficiency. With Permira’s support, the combined company will have the resources to continue innovating and catering to the evolving needs of patients and biopharmaceutical companies.

Contact the Harris Williams Healthcare & Life Sciences Group to learn more about this client engagement.